Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Gerl

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
Der Internist|July 1, 1993
[Indurating soft tissue swelling, eosinophilia and increased blood sedimentation rate]A Gerl, P Kohl, J Niedermaier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic diseaseA Gerl, C Clemm, R Lamerz, et al.
Cancer|April 3, 2001
The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumorsA Gerl, D Mühlbayer, G Hansmann, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
Etoposide, cisplatin, bleomycin, and cyclophosphamide (ECBC) as first-line chemotherapy for poor-risk non-seminomatous germ cell tumorsA Gerl, C Clemm, M Hentrich, et al.
Clinical & Experimental Metastasis|May 1, 1994
Central nervous system as sanctuary site of relapse in patients treated with chemotherapy for metastatic testicular cancerA Gerl, C Clemm, P Kohl, et al.
Anticancer Research|July 1, 1997
Is serum tumor marker half-life a guide to prognosis in metastatic nonseminomatous germ cell tumors?A Gerl, R Lamerz, K Mann, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 15, 1994
[Primary extragonadal germ cell tumors. Clinical manifestations, differential diagnosis and therapy]A Gerl, C Clemm, P Kohl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2010
Myocardial infarction and other major vascular events during chemotherapy for testicular cancerK-P Dieckmann, A Gerl, J Witt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysisJ Beyer, S Stenning, A Gerl, et al.
Der Internist|September 1, 1990
[Septic temperatures and throat pain in a patient with hyperthyroidism]A Gerl, R Forstpointner, A Schalhorn, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
Der Internist|July 1, 1993
[Indurating soft tissue swelling, eosinophilia and increased blood sedimentation rate]A Gerl, P Kohl, J Niedermaier, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Prognostic implications of tumour marker analysis in non-seminomatous germ cell tumours with poor prognosis metastatic diseaseA Gerl, C Clemm, R Lamerz, et al.
Cancer|April 3, 2001
The impact of chemotherapy on Leydig cell function in long term survivors of germ cell tumorsA Gerl, D Mühlbayer, G Hansmann, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1993
Etoposide, cisplatin, bleomycin, and cyclophosphamide (ECBC) as first-line chemotherapy for poor-risk non-seminomatous germ cell tumorsA Gerl, C Clemm, M Hentrich, et al.
Clinical & Experimental Metastasis|May 1, 1994
Central nervous system as sanctuary site of relapse in patients treated with chemotherapy for metastatic testicular cancerA Gerl, C Clemm, P Kohl, et al.
Anticancer Research|July 1, 1997
Is serum tumor marker half-life a guide to prognosis in metastatic nonseminomatous germ cell tumors?A Gerl, R Lamerz, K Mann, et al.
Medizinische Klinik (Munich, Germany : 1983)|May 15, 1994
[Primary extragonadal germ cell tumors. Clinical manifestations, differential diagnosis and therapy]A Gerl, C Clemm, P Kohl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 14, 2010
Myocardial infarction and other major vascular events during chemotherapy for testicular cancerK-P Dieckmann, A Gerl, J Witt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2002
High-dose versus conventional-dose chemotherapy as first-salvage treatment in patients with non-seminomatous germ-cell tumors: a matched-pair analysisJ Beyer, S Stenning, A Gerl, et al.
Der Internist|September 1, 1990
[Septic temperatures and throat pain in a patient with hyperthyroidism]A Gerl, R Forstpointner, A Schalhorn, et al.
Pageof 8